FROM Rob Stein
Should Homeopathic Remedies Be Regulated? Americans who distrust pharmaceutical companies have helped make homeopathic remedies a multi-billion-dollar industry, but critics say it needs more oversight. So-called "natural remedies" are hugely profitable due to increasing popularity. Before hearings began today, the FDA was flooded with public comments. The Center for Inquiry is a nonprofit advocacy group that's pushing the FDA for stricter regulation. Michael De Dora is Director of Public Policy, and he testified at today's first of two sessions. Rob Stein, correspondent and senior editor on NPR 's science desk, has been covering this issue.
First Patient Treated in Stem Cell Study Last Friday, researchers in Atlanta injected millions of embryonic stem cells into a patient with a damaged spine, in the first clinical trial of embryonic stem cells in a human being. Phase I is for safety, but they're looking for therapeutic consequences as well. Some critics say it's premature, while others contend it's immoral. Rob Stein is national science reporter at the Washington Post .
Swine Flu Vaccine Rollout Today Billions of tax dollars have been paid to pharmaceutical giants, millions of doses of vaccine are on their way to huge warehouses and thousands of health workers are waiting. That's according to the Washington Post, which then asks, " will Americans line up " to be vaccinated for swine flu? It's the most ambitious inoculation campaign in American history, but polls show the public is "decidedly ambivalent." Rob Stein is national science reporter for the Washington Post.
Trump's 'America First' goes missing abroad In the Middle East, President Trump is changing some policies of the Obama Administration—and reversing his own campaign attacks on Islam as a religion that "hates us." We hear about his visit to Saudi Arabia and what's at stake for the rest of his foreign excursion.
Ex-FBI Director Comey tells his side of the story Today, former FBI Director James Comey came close to calling the President who fired him a liar. The White House denied the claim and called it insulting, but Republican Senators did not challenge Comey’s truthfulness. Many questions remain: did the President try to obstruct a federal investigation? Later, we’ll go behind the “velvet rope” for a look at 5-Star health care for the richest Americans.
Replacing Obamacare: Now you see it… now you don’t As the Senate deliberates replacing Obmacare, health coverage for millions of people is at stake. There've been no public hearings, and a draft measure won't be made public. Is the House version so unpopular that that Senate is hiding a version that looks much the same?
The Trump agenda: where's the beef? President Trump says big things are happening. After celebrating a House bill on health care, he doesn’t yet have Senate agreement. With James Comey’s public testimony scheduled tomorrow, the President today tweeted his selection of a new FBI Director. Is the Chief Executive all style and no substance? Later, terror attacks in Iran and conflicting claims about who’s behind them.